Kiora Pharmaceuticals Stock Fair Value – Kiora Pharmaceuticals Stock Plummets 50% Following $5.5M Public Offering

🌥️Trending News Kiora Pharmaceuticals ($NASDAQ:KPRX), a biopharmaceutical company focused on the development of innovative treatments for serious diseases, has recently [...]

By |June 3, 2023|Categories: Biotechnology, Intrinsic Value|Tags: , , |0 Comments

Autolus Therapeutics Shares Rise After Presentation of Positive Phase 2 Leukemia Therapy Data

☀️Trending News Autolus Therapeutics ($NASDAQ:AUTL), a biopharmaceutical company developing next-generation T-cell therapies for the treatment of cancer, recently presented data [...]

By |June 3, 2023|Categories: Biotechnology|Tags: , , |0 Comments

Lixte Biotechnology Stock Intrinsic Value – LIXTE Biotechnology Holdings Announces Reverse Stock Split to Comply with Minimum Price Requirements

🌥️Trending News LIXTE ($NASDAQ:LIXT) Biotechnology Holdings (LIXTE) has announced a reverse stock split to comply with the minimum price requirements [...]

By |June 3, 2023|Categories: Biotechnology, Uncategorized|Tags: , , |0 Comments

Oncorus Intrinsic Value Calculation – ONCORUS Facing Bankruptcy as 43% of Employees Laid Off

🌥️Trending News Oncorus ($NASDAQ:ONCR) is a publicly-traded biotechnology company dedicated to the discovery and development of innovative treatments and cures [...]

By |June 3, 2023|Categories: Biotechnology, Intrinsic Value|Tags: , , |0 Comments

Adaptimmune Therapeutics Stock Intrinsic Value – ADAPTIMMUNE THERAPEUTICS Reports Q1 Revenue of $47.6M, Exceeding Street Estimate of $4.6M.

🌥️Trending News ADAPTIMMUNE THERAPEUTICS ($NASDAQ:ADAP), a biopharmaceutical company that focuses on developing engineered T-cell therapies, recently reported its Q1 revenue [...]

By |June 3, 2023|Categories: Biotechnology, Intrinsic Value, Profitability|Tags: , , |0 Comments
Go to Top